ID26665A - VLA-4 ANTAGONISTS - Google Patents

VLA-4 ANTAGONISTS

Info

Publication number
ID26665A
ID26665A IDW20001404A ID20001404A ID26665A ID 26665 A ID26665 A ID 26665A ID W20001404 A IDW20001404 A ID W20001404A ID 20001404 A ID20001404 A ID 20001404A ID 26665 A ID26665 A ID 26665A
Authority
ID
Indonesia
Prior art keywords
vla
antagonists
Prior art date
Application number
IDW20001404A
Other languages
Indonesian (id)
Inventor
Sompong Wattanasin
Peter Joseph Von Matt
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID26665A publication Critical patent/ID26665A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW20001404A 1998-01-23 1999-01-21 VLA-4 ANTAGONISTS ID26665A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1233698A 1998-01-23 1998-01-23
US11072398P 1998-12-03 1998-12-03

Publications (1)

Publication Number Publication Date
ID26665A true ID26665A (en) 2001-01-25

Family

ID=26683440

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001404A ID26665A (en) 1998-01-23 1999-01-21 VLA-4 ANTAGONISTS

Country Status (13)

Country Link
EP (1) EP1049665A1 (en)
JP (1) JP4564654B2 (en)
KR (1) KR20010034317A (en)
CN (1) CN1294576A (en)
AU (1) AU746174B2 (en)
BR (1) BR9907733A (en)
CA (1) CA2318639A1 (en)
EE (1) EE200000428A (en)
HU (1) HUP0100336A3 (en)
ID (1) ID26665A (en)
IL (1) IL137329A0 (en)
NO (1) NO20003694L (en)
WO (1) WO1999037605A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60036918D1 (en) 1999-01-22 2007-12-13 Elan Pharm Inc COMPOUNDS INHIBITING THE VLA-4-MEDIATED ADHESION OF LEUKOCYTES
WO2000043372A1 (en) * 1999-01-22 2000-07-27 Elan Pharmaceuticals, Inc. Acyl derivatives which treat vla-4 related disorders
US6436904B1 (en) 1999-01-25 2002-08-20 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
WO2000051974A1 (en) 1999-03-01 2000-09-08 Elan Pharmaceuticals, Inc. Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists
JP2003516380A (en) * 1999-12-07 2003-05-13 ノバルティス アクチエンゲゼルシャフト VLA-4 integrin antagonist
PL357109A1 (en) 1999-12-28 2004-07-12 Pfizer Products Inc. Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
DE10019755A1 (en) * 2000-04-20 2001-11-08 Bayer Ag New cyclic carboxylic acids are integrin antagonists, useful for treating inflammatory diseases, autoimmune and immune disorders, e.g. atherosclerosis, asthma and diabetes
GB2367816A (en) * 2000-10-09 2002-04-17 Bayer Ag Urea- and thiourea-containing derivatives of beta-amino acids
GB2369357A (en) * 2000-10-09 2002-05-29 Bayer Ag Aliphatic, cyclic amino carboxylic acids as integrin antagonists
GB2377933A (en) 2001-07-06 2003-01-29 Bayer Ag Succinic acid derivatives useful as integrin antagonists
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TW200610754A (en) * 2004-06-14 2006-04-01 Daiichi Seiyaku Co Vla-4 inhibitor
GB0523576D0 (en) * 2005-11-18 2005-12-28 Theradeas Ltd Drug composition and its use in therapy
WO2008103378A2 (en) 2007-02-20 2008-08-28 Merrimack Pharmaceuticals, Inc. Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
PL2288715T3 (en) 2008-04-11 2015-03-31 Merrimack Pharmaceuticals Inc Human serum albumin linkers and conjugates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306840B1 (en) * 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
IL136584A (en) * 1997-12-23 2005-03-20 Aventis Pharma Ltd SUBSTITUTED beta-ALANINES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USES THEREOF

Also Published As

Publication number Publication date
EE200000428A (en) 2001-12-17
NO20003694L (en) 2000-09-20
NO20003694D0 (en) 2000-07-19
EP1049665A1 (en) 2000-11-08
CN1294576A (en) 2001-05-09
JP4564654B2 (en) 2010-10-20
JP2002501039A (en) 2002-01-15
IL137329A0 (en) 2001-07-24
WO1999037605A1 (en) 1999-07-29
HUP0100336A2 (en) 2001-07-30
BR9907733A (en) 2000-10-17
KR20010034317A (en) 2001-04-25
CA2318639A1 (en) 1999-07-29
HUP0100336A3 (en) 2002-11-28
AU746174B2 (en) 2002-04-18
AU2829299A (en) 1999-08-09

Similar Documents

Publication Publication Date Title
DE69930183D1 (en) anesthesia machine
DE60000003T2 (en) paroxetine
NO990113D0 (en) Multihull-speed ° y
ID23761A (en) SUBSTITUTED TRISICLIC
NO992692D0 (en) Nefadozone dosage form
NO994626D0 (en) Substituted benzamides
EE200000171A (en) New NPY antagonists
DE69908262D1 (en) spray
ID26665A (en) VLA-4 ANTAGONISTS
ID26223A (en) VITRONEKTIN RECEPTOR ANTAGONISTS
ID29914A (en) HYPEROSICLIC BENZENSULFONAMIDE COMPOUNDS AS BRADICININE ANTAGONISTS
ID23219A (en) SUBSTITUTED TRISICLIC
ID22838A (en) OKSAZOLIDINA AS 5-HT2A ANTAGONISTS
ID27845A (en) TETRAHIDROKUILINA DECREASED AS GLISILINA ANTAGONISTS
ID28811A (en) VITRONEKTIN RECEPTOR ANTAGONISTS
NO990717D0 (en) Monitor st ° ttemekanisme
DE59907109D1 (en) lapper
FR2782671B3 (en) DELIVERED
DE59907108D1 (en) lapper
ID26508A (en) SUBSTITUTED OXIMS AS NEUROKININ ANTAGONISTS
ATE303996T1 (en) SUBSTITUTED ACYLAMINOPHENYL URACILES
DE59912188D1 (en) SUBSTITUTED PHENYLURACILE
DE59911610D1 (en) SUBSTITUTED BENZOYLCYCLOHEXANDIONE
FI980856A0 (en) Andningsskydd utrustad med en identifierare
DE59903934D1 (en) SPRAY CAN